&quot;Sattva Neelapu @MDAndersonNews discusses ﬁrst in human data with allogeneic gamma/delta CD20 #CARTcells ADI-001 in #lymphoma @ASTCT @CIBMTR 75% ORR 69% CR No #GVHD or grade 3/4 CRS or ICANS. 100% CR in 5 pts with LBCL after prior CD19 CAR T therapy #Tandem23&quot;